James McCaw,
Genetic Counseling Assistant
Department:
Pediatric Genetics and Metabolism
Business Phone:
(352) 294-5050
Business Email:
jmccaw@ufl.edu
Publications
Academic Articles
2024
Key Challenges for Respiratory Virus Surveillance while Transitioning out of Acute Phase of COVID-19 Pandemic.
Emerging infectious diseases.
30(2)
[DOI] 10.3201/eid3002.230768.
[PMID] 38190760.
2023
A model for malaria treatment evaluation in the presence of multiple species.
Epidemics.
44
[DOI] 10.1016/j.epidem.2023.100687.
[PMID] 37348379.
2023
A modelling approach to estimate the transmissibility of SARS-CoV-2 during periods of high, low, and zero case incidence.
eLife.
12
[DOI] 10.7554/eLife.78089.
[PMID] 36661303.
2023
Choice of spatial discretisation influences the progression of viral infection within multicellular tissues.
Journal of theoretical biology.
573
[DOI] 10.1016/j.jtbi.2023.111592.
[PMID] 37558160.
2023
COVID-19 vaccine coverage targets to inform reopening plans in a low incidence setting.
Proceedings. Biological sciences.
290(2005)
[DOI] 10.1098/rspb.2023.1437.
[PMID] 37644838.
2023
Cross-sectional study in Madagascar demonstrates efficacy of virtual mentoring and flipped classroom modifications of neonatal resuscitation programme Helping Babies Breathe.
Acta paediatrica (Oslo, Norway : 1992).
112(8):1783-1789
[DOI] 10.1111/apa.16819.
[PMID] 37159532.
2023
Enhanced viral infectivity and reduced interferon production are associated with high pathogenicity for influenza viruses.
PLoS computational biology.
19(2)
[DOI] 10.1371/journal.pcbi.1010886.
[PMID] 36758109.
2023
Forecasting COVID-19 activity in Australia to support pandemic response: May to October 2020.
Scientific reports.
13(1)
[DOI] 10.1038/s41598-023-35668-6.
[PMID] 37253758.
2023
How effective were Australian Quarantine Stations in mitigating transmission aboard ships during the influenza pandemic of 1918-19?
PLoS computational biology.
19(11)
[DOI] 10.1371/journal.pcbi.1011656.
[PMID] 38011267.
2023
Improving estimates of waning immunity rates in stochastic SIRS models with a hierarchical framework.
Infectious Disease Modelling.
8(4):1127-1137
[DOI] 10.1016/j.idm.2023.10.002.
[PMID] 37886740.
2023
Individual variation in vaccine immune response can produce bimodal distributions of protection.
Vaccine.
41(45):6630-6636
[DOI] 10.1016/j.vaccine.2023.09.025.
[PMID] 37793975.
2023
Optimal Interruption of P. vivax Malaria Transmission Using Mass Drug Administration.
Bulletin of mathematical biology.
85(6)
[DOI] 10.1007/s11538-023-01153-4.
[PMID] 37076740.
2023
Real-time analysis of hospital length of stay in a mixed SARS-CoV-2 Omicron and Delta epidemic in New South Wales, Australia.
BMC infectious diseases.
23(1)
[DOI] 10.1186/s12879-022-07971-6.
[PMID] 36650474.
2023
Seasonality as a driver of pH1N12009 influenza vaccination campaign impact.
Epidemics.
45
[DOI] 10.1016/j.epidem.2023.100730.
[PMID] 38056164.
2023
Superinfection and the hypnozoite reservoir for Plasmodium vivax: a general framework.
Journal of mathematical biology.
88(1)
[DOI] 10.1007/s00285-023-02014-3.
[PMID] 38040981.
2023
Understanding the impact of disease and vaccine mechanisms on the importance of optimal vaccine allocation.
Infectious Disease Modelling.
8(2):539-550
[DOI] 10.1016/j.idm.2023.05.003.
[PMID] 37288288.
2022
A Multiscale Mathematical Model of Plasmodium Vivax Transmission.
Bulletin of mathematical biology.
84(8)
[DOI] 10.1007/s11538-022-01036-0.
[PMID] 35778540.
2022
COVID-19 in low-tolerance border quarantine systems: Impact of the Delta variant of SARS-CoV-2.
Science advances.
8(14)
[DOI] 10.1126/sciadv.abm3624.
[PMID] 35394833.
2022
Estimation of the probability of epidemic fade-out from multiple outbreak data.
Epidemics.
38
[DOI] 10.1016/j.epidem.2022.100539.
[PMID] 35093850.
2022
Hypnozoite dynamics for Plasmodium vivax malaria: The epidemiological effects of radical cure.
Journal of theoretical biology.
537
[DOI] 10.1016/j.jtbi.2022.111014.
[PMID] 35016895.
2022
Rapid assessment of the risk of SARS-CoV-2 importation: case study and lessons learned.
Epidemics.
38
[DOI] 10.1016/j.epidem.2022.100549.
[PMID] 35255398.
2021
Antibody Dynamics for Plasmodium vivax Malaria: A Mathematical Model.
Bulletin of mathematical biology.
83(1)
[DOI] 10.1007/s11538-020-00837-5.
[PMID] 33387082.
2021
Constructing an ethical framework for priority allocation of pandemic vaccines.
Vaccine.
39(5):797-804
[DOI] 10.1016/j.vaccine.2020.12.053.
[PMID] 33408013.
2021
Development and Validation of an In Silico Decision Tool To Guide Optimization of Intravenous Artesunate Dosing Regimens for Severe Falciparum Malaria Patients.
Antimicrobial agents and chemotherapy.
65(6)
[DOI] 10.1128/AAC.02346-20.
[PMID] 33685888.
2021
Development of an influenza pandemic decision support tool linking situational analytics to national response policy.
Epidemics.
36
[DOI] 10.1016/j.epidem.2021.100478.
[PMID] 34174521.
2021
Modelling the Effect of MUC1 on Influenza Virus Infection Kinetics and Macrophage Dynamics.
Viruses.
13(5)
[DOI] 10.3390/v13050850.
[PMID] 34066999.
2021
Modelling within-host macrophage dynamics in influenza virus infection.
Journal of theoretical biology.
508
[DOI] 10.1016/j.jtbi.2020.110492.
[PMID] 32966828.
2020
An Activation-Clearance Model for Plasmodium vivax Malaria.
Bulletin of mathematical biology.
82(2)
[DOI] 10.1007/s11538-020-00706-1.
[PMID] 32052192.
2020
Coordinating the real-time use of global influenza activity data for better public health planning.
Influenza and other respiratory viruses.
14(2):105-110
[DOI] 10.1111/irv.12705.
[PMID] 32096594.
2020
Coronavirus Disease Model to Inform Transmission-Reducing Measures and Health System Preparedness, Australia.
Emerging infectious diseases.
26(12):2844-2853
[DOI] 10.3201/eid2612.202530.
[PMID] 32985971.
2020
Early analysis of the Australian COVID-19 epidemic.
eLife.
9
[DOI] 10.7554/eLife.58785.
[PMID] 32788039.
2020
Estimation of the force of infection and infectious period of skin sores in remote Australian communities using interval-censored data.
PLoS computational biology.
16(10)
[DOI] 10.1371/journal.pcbi.1007838.
[PMID] 33017395.
2020
Infectious disease pandemic planning and response: Incorporating decision analysis.
PLoS medicine.
17(1)
[DOI] 10.1371/journal.pmed.1003018.
[PMID] 31917786.
2020
Influencing public health policy with data-informed mathematical models of infectious diseases: Recent developments and new challenges.
Epidemics.
32
[DOI] 10.1016/j.epidem.2020.100393.
[PMID] 32674025.
2020
Key questions for modelling COVID-19 exit strategies.
Proceedings. Biological sciences.
287(1932)
[DOI] 10.1098/rspb.2020.1405.
[PMID] 32781946.
2019
A biological model of scabies infection dynamics and treatment informs mass drug administration strategies to increase the likelihood of elimination.
Mathematical biosciences.
309:163-173
[DOI] 10.1016/j.mbs.2018.08.007.
[PMID] 30149021.
2019
A simple influenza model with complicated dynamics.
Journal of mathematical biology.
78(3):607-624
[DOI] 10.1007/s00285-018-1285-z.
[PMID] 30155777.
2019
Accounting for Healthcare-Seeking Behaviours and Testing Practices in Real-Time Influenza Forecasts.
Tropical medicine and infectious disease.
4(1)
[DOI] 10.3390/tropicalmed4010012.
[PMID] 30641917.
2019
Anatomy of a seasonal influenza epidemic forecast.
Communicable diseases intelligence (2018).
43
[DOI] 10.33321/cdi.2019.43.7.
[PMID] 30879285.
2019
Modeling the dynamics of Plasmodium falciparum gametocytes in humans during malaria infection.
eLife.
8
[DOI] 10.7554/eLife.49058.
[PMID] 31658944.
2019
Sequential infection experiments for quantifying innate and adaptive immunity during influenza infection.
PLoS computational biology.
15(1)
[DOI] 10.1371/journal.pcbi.1006568.
[PMID] 30653522.
2018
Calculation of the age of the first infection for skin sores and scabies in five remote communities in northern Australia.
Epidemiology and infection.
146(9):1194-1201
[DOI] 10.1017/S0950268818001061.
[PMID] 29734959.
2018
Characterization of Influenza B Virus Variants with Reduced Neuraminidase Inhibitor Susceptibility.
Antimicrobial agents and chemotherapy.
62(11)
[DOI] 10.1128/AAC.01081-18.
[PMID] 30201817.
2018
Clonally diverse CD38+HLA-DR+CD8+ T cells persist during fatal H7N9 disease.
Nature communications.
9(1)
[DOI] 10.1038/s41467-018-03243-7.
[PMID] 29483513.
2018
Epidemic forecasts as a tool for public health: interpretation and (re)calibration.
Australian and New Zealand journal of public health.
42(1):69-76
[DOI] 10.1111/1753-6405.12750.
[PMID] 29281169.
2018
Evidence for Viral Interference and Cross-reactive Protective Immunity Between Influenza B Virus Lineages.
The Journal of infectious diseases.
217(4):548-559
[DOI] 10.1093/infdis/jix509.
[PMID] 29325138.
2018
In Silico Investigation of the Decline in Clinical Efficacy of Artemisinin Combination Therapies Due to Increasing Artemisinin and Partner Drug Resistance.
Antimicrobial agents and chemotherapy.
62(12)
[DOI] 10.1128/AAC.01292-18.
[PMID] 30249691.
2018
Infection-acquired versus vaccine-acquired immunity in an SIRWS model.
Infectious Disease Modelling.
3:118-135
[DOI] 10.1016/j.idm.2018.06.002.
[PMID] 30839933.
2018
Investigating the Efficacy of Triple Artemisinin-Based Combination Therapies for Treating Plasmodium falciparum Malaria Patients Using Mathematical Modeling.
Antimicrobial agents and chemotherapy.
62(11)
[DOI] 10.1128/AAC.01068-18.
[PMID] 30150462.
2018
Investigating Viral Interference Between Influenza A Virus and Human Respiratory Syncytial Virus in a Ferret Model of Infection.
The Journal of infectious diseases.
218(3):406-417
[DOI] 10.1093/infdis/jiy184.
[PMID] 29746640.
2018
Predicting the Outcomes of New Short-Course Regimens for Multidrug-Resistant Tuberculosis Using Intrahost and Pharmacokinetic-Pharmacodynamic Modeling.
Antimicrobial agents and chemotherapy.
62(12)
[DOI] 10.1128/AAC.01487-18.
[PMID] 30249697.
2018
The distribution of the time taken for an epidemic to spread between two communities.
Mathematical biosciences.
303:139-147
[DOI] 10.1016/j.mbs.2018.07.004.
[PMID] 30089576.
2018
Within-host modeling of blood-stage malaria.
Immunological reviews.
285(1):168-193
[DOI] 10.1111/imr.12697.
[PMID] 30129195.
2017
A Dynamic Stress Model Explains the Delayed Drug Effect in Artemisinin Treatment of Plasmodium falciparum.
Antimicrobial agents and chemotherapy.
61(12)
[DOI] 10.1128/AAC.00618-17.
[PMID] 28993326.
2017
A mechanistic model quantifies artemisinin-induced parasite growth retardation in blood-stage Plasmodium falciparum infection.
Journal of theoretical biology.
430:117-127
[DOI] 10.1016/j.jtbi.2017.07.017.
[PMID] 28728995.
2017
Characterising pandemic severity and transmissibility from data collected during first few hundred studies.
Epidemics.
19:61-73
[DOI] 10.1016/j.epidem.2017.01.004.
[PMID] 28189386.
2017
Corrigendum to ”Modelling cross-reactivity and memory in the cellular adaptive immune response to influenza infection in the host” [J.Theor. Biol. 413 (2017) 34-49].
Journal of theoretical biology.
419
[DOI] 10.1016/j.jtbi.2017.03.015.
[PMID] 28363398.
2017
Influenza as a trigger for cardiovascular disease: An investigation of serotype, subtype and geographic location.
Environmental research.
156:688-696
[DOI] 10.1016/j.envres.2017.04.024.
[PMID] 28477579.
2017
Model selection for seasonal influenza forecasting.
Infectious Disease Modelling.
2(1):56-70
[DOI] 10.1016/j.idm.2016.12.004.
[PMID] 29928729.
2017
Modelling cross-reactivity and memory in the cellular adaptive immune response to influenza infection in the host.
Journal of theoretical biology.
413:34-49
[DOI] 10.1016/j.jtbi.2016.11.008.
[PMID] 27856216.
2017
Retrospective forecasting of the 2010-2014 Melbourne influenza seasons using multiple surveillance systems.
Epidemiology and infection.
145(1):156-169
[PMID] 27671159.
2017
The Mechanisms for Within-Host Influenza Virus Control Affect Model-Based Assessment and Prediction of Antiviral Treatment.
Viruses.
9(8)
[DOI] 10.3390/v9080197.
[PMID] 28933757.
2017
Turnover of Village Chickens Undermines Vaccine Coverage to Control HPAI H5N1.
Zoonoses and public health.
64(1):53-62
[DOI] 10.1111/zph.12282.
[PMID] 27357237.
2016
Comparison of the Exposure Time Dependence of the Activities of Synthetic Ozonide Antimalarials and Dihydroartemisinin against K13 Wild-Type and Mutant Plasmodium falciparum Strains.
Antimicrobial agents and chemotherapy.
60(8):4501-10
[DOI] 10.1128/AAC.00574-16.
[PMID] 27161632.
2016
Forecasting influenza outbreak dynamics in Melbourne from Internet search query surveillance data.
Influenza and other respiratory viruses.
10(4):314-23
[DOI] 10.1111/irv.12376.
[PMID] 26859411.
2016
Heightened self-reactivity associated with selective survival, but not expansion, of naïve virus-specific CD8+ T cells in aged mice.
Proceedings of the National Academy of Sciences of the United States of America.
113(5):1333-8
[DOI] 10.1073/pnas.1525167113.
[PMID] 26787864.
2016
High conservation level of CD8(+) T cell immunogenic regions within an unusual H1N2 human influenza variant.
Journal of medical virology.
88(10):1725-32
[DOI] 10.1002/jmv.24516.
[PMID] 26950895.
2016
Model-Informed Risk Assessment and Decision Making for an Emerging Infectious Disease in the Asia-Pacific Region.
PLoS neglected tropical diseases.
10(9)
[DOI] 10.1371/journal.pntd.0005018.
[PMID] 27661978.
2016
On the extinction probability in models of within-host infection: the role of latency and immunity.
Journal of mathematical biology.
73(4):787-813
[DOI] 10.1007/s00285-015-0961-5.
[PMID] 26748917.
2016
On the Role of CD8+ T Cells in Determining Recovery Time from Influenza Virus Infection.
Frontiers in immunology.
7
[DOI] 10.3389/fimmu.2016.00611.
[PMID] 28066421.
2016
Parasite Strain, Host Immunity, and Circulating Blood Cells with Dead Parasites: Why Predicting Malaria Parasite Clearance Is Not a Simple Task.
Antimicrobial agents and chemotherapy.
60(2)
[DOI] 10.1128/AAC.02528-15.
[PMID] 26826193.
2016
Periodic solutions in an SIRWS model with immune boosting and cross-immunity.
Journal of theoretical biology.
410:55-64
[DOI] 10.1016/j.jtbi.2016.08.034.
[PMID] 27575466.
2016
Reducing disease burden in an influenza pandemic by targeted delivery of neuraminidase inhibitors: mathematical models in the Australian context.
BMC infectious diseases.
16(1)
[PMID] 27724915.
2015
A new approach to estimating trends in chlamydia incidence.
Sexually transmitted infections.
91(7):513-9
[DOI] 10.1136/sextrans-2014-051631.
[PMID] 25564675.
2015
Defining long-term drivers of pertussis resurgence, and optimal vaccine control strategies.
Vaccine.
33(43):5794-5800
[DOI] 10.1016/j.vaccine.2015.09.025.
[PMID] 26392008.
2015
Factors associated with transmission of influenza-like illness in a cohort of households containing multiple children.
Influenza and other respiratory viruses.
9(5):247-54
[DOI] 10.1111/irv.12331.
[PMID] 26061755.
2015
Innate Immunity and the Inter-exposure Interval Determine the Dynamics of Secondary Influenza Virus Infection and Explain Observed Viral Hierarchies.
PLoS computational biology.
11(8)
[DOI] 10.1371/journal.pcbi.1004334.
[PMID] 26284917.
2015
Interval Between Infections and Viral Hierarchy Are Determinants of Viral Interference Following Influenza Virus Infection in a Ferret Model.
The Journal of infectious diseases.
212(11):1701-10
[DOI] 10.1093/infdis/jiv260.
[PMID] 25943206.
2015
Pertussis models to inform vaccine policy.
Human vaccines & immunotherapeutics.
11(3):669-78
[DOI] 10.1080/21645515.2015.1011575.
[PMID] 25714499.
2015
Prior population immunity reduces the expected impact of CTL-inducing vaccines for pandemic influenza control.
PloS one.
10(3)
[DOI] 10.1371/journal.pone.0120138.
[PMID] 25811654.
2015
Quantifying differences in the epidemic curves from three influenza surveillance systems: a nonlinear regression analysis.
Epidemiology and infection.
143(2):427-39
[DOI] 10.1017/S0950268814000764.
[PMID] 24759447.
2015
Quantifying relative within-host replication fitness in influenza virus competition experiments.
Journal of theoretical biology.
382:259-71
[DOI] 10.1016/j.jtbi.2015.07.003.
[PMID] 26188087.
2015
Social encounter profiles of greater Melbourne residents, by location–a telephone survey.
BMC infectious diseases.
15
[DOI] 10.1186/s12879-015-1237-9.
[PMID] 26525046.
2015
Targeting the cell stress response of Plasmodium falciparum to overcome artemisinin resistance.
PLoS biology.
13(4)
[DOI] 10.1371/journal.pbio.1002132.
[PMID] 25901609.
2015
The effects of demographic change on disease transmission and vaccine impact in a household structured population.
Epidemics.
13:56-64
[DOI] 10.1016/j.epidem.2015.08.002.
[PMID] 26616042.
2014
Dynamical crises, multistability and the influence of the duration of immunity in a seasonally-forced model of disease transmission.
Theoretical biology & medical modelling.
11
[DOI] 10.1186/1742-4682-11-43.
[PMID] 25280872.
2014
Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses.
PLoS pathogens.
10(4)
[DOI] 10.1371/journal.ppat.1004065.
[PMID] 24699865.
2014
Evaluation of oseltamivir prophylaxis regimens for reducing influenza virus infection, transmission and disease severity in a ferret model of household contact.
The Journal of antimicrobial chemotherapy.
69(9):2458-69
[DOI] 10.1093/jac/dku146.
[PMID] 24840623.
2014
Making the most of clinical data: reviewing the role of pharmacokinetic-pharmacodynamic models of anti-malarial drugs.
The AAPS journal.
16(5):962-74
[DOI] 10.1208/s12248-014-9647-y.
[PMID] 25056904.
2014
Pandemic controllability: a concept to guide a proportionate and flexible operational response to future influenza pandemics.
Journal of public health (Oxford, England).
36(1):5-12
[DOI] 10.1093/pubmed/fdt058.
[PMID] 23735960.
2014
Population pharmacokinetics of intravenous artesunate: a pooled analysis of individual data from patients with severe malaria.
CPT: pharmacometrics & systems pharmacology.
3(11)
[DOI] 10.1038/psp.2014.43.
[PMID] 25372510.
2014
The dynamical consequences of seasonal forcing, immune boosting and demographic change in a model of disease transmission.
Journal of theoretical biology.
361:124-32
[DOI] 10.1016/j.jtbi.2014.07.028.
[PMID] 25106793.
2014
The influence of changing host immunity on 1918-19 pandemic dynamics.
Epidemics.
8:18-27
[DOI] 10.1016/j.epidem.2014.07.004.
[PMID] 25240900.
2013
Altered temporal response of malaria parasites determines differential sensitivity to artemisinin.
Proceedings of the National Academy of Sciences of the United States of America.
110(13):5157-62
[DOI] 10.1073/pnas.1217452110.
[PMID] 23431146.
2013
Antigenic drift of the pandemic 2009 A(H1N1) influenza virus in A ferret model.
PLoS pathogens.
9(5)
[DOI] 10.1371/journal.ppat.1003354.
[PMID] 23671418.
2013
Reducing uncertainty in within-host parameter estimates of influenza infection by measuring both infectious and total viral load.
PloS one.
8(5)
[DOI] 10.1371/journal.pone.0064098.
[PMID] 23691157.
2013
Virus detection and its association with symptoms during influenza-like illness in a sample of healthy adults enrolled in a randomised controlled vaccine trial.
Influenza and other respiratory viruses.
7(3):330-9
[DOI] 10.1111/j.1750-2659.2012.00395.x.
[PMID] 22712831.
2012
Application of a case-control study design to investigate genotypic signatures of HIV-1 transmission.
Retrovirology.
9
[DOI] 10.1186/1742-4690-9-54.
[PMID] 22731404.
2012
Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development.
Malaria journal.
11
[DOI] 10.1186/1475-2875-11-303.
[PMID] 22931058.
2012
Drivers and consequences of influenza antiviral resistant-strain emergence in a capacity-constrained pandemic response.
Epidemics.
4(4):219-26
[DOI] 10.1016/j.epidem.2012.12.002.
[PMID] 23351374.
2012
Household transmission of respiratory viruses – assessment of viral, individual and household characteristics in a population study of healthy Australian adults.
BMC infectious diseases.
12
[DOI] 10.1186/1471-2334-12-345.
[PMID] 23231698.
2012
Influence of contact definitions in assessment of the relative importance of social settings in disease transmission risk.
PloS one.
7(2)
[DOI] 10.1371/journal.pone.0030893.
[PMID] 22359553.
2012
Likely effectiveness of pharmaceutical and non-pharmaceutical interventions for mitigating influenza virus transmission in Mongolia.
Bulletin of the World Health Organization.
90(4):264-71
[DOI] 10.2471/BLT.11.093419.
[PMID] 22511822.
2011
A mathematical framework for estimating pathogen transmission fitness and inoculum size using data from a competitive mixtures animal model.
PLoS computational biology.
7(4)
[DOI] 10.1371/journal.pcbi.1002026.
[PMID] 21552544.
2011
Diagnosis and antiviral intervention strategies for mitigating an influenza epidemic.
PloS one.
6(2)
[DOI] 10.1371/journal.pone.0014505.
[PMID] 21346794.
2011
Incorporating population dynamics into household models of infectious disease transmission.
Epidemics.
3(3-4):152-8
[DOI] 10.1016/j.epidem.2011.05.001.
[PMID] 22094338.
2011
Understanding mortality in the 1918-1919 influenza pandemic in England and Wales.
Influenza and other respiratory viruses.
5(2):89-98
[DOI] 10.1111/j.1750-2659.2010.00186.x.
[PMID] 21306572.
2010
Assessing the viral fitness of oseltamivir-resistant influenza viruses in ferrets, using a competitive-mixtures model.
Journal of virology.
84(18):9427-38
[DOI] 10.1128/JVI.00373-10.
[PMID] 20631138.
2010
Comparison of three methods for ascertainment of contact information relevant to respiratory pathogen transmission in encounter networks.
BMC infectious diseases.
10
[DOI] 10.1186/1471-2334-10-166.
[PMID] 20537186.
2010
Modelling strategic use of the national antiviral stockpile during the CONTAIN and SUSTAIN phases of an Australian pandemic influenza response.
Australian and New Zealand journal of public health.
34(2):113-9
[DOI] 10.1111/j.1753-6405.2010.00493.x.
[PMID] 23331352.
2010
Prior immunity helps to explain wave-like behaviour of pandemic influenza in 1918-9.
BMC infectious diseases.
10
[DOI] 10.1186/1471-2334-10-128.
[PMID] 20497585.
2009
Influenza: accounting for prior immunity.
Science (New York, N.Y.).
325(5944):1071; author reply 1072-3
[DOI] 10.1126/science.325_1071a.
[PMID] 19713508.
2009
Optimal dosing and dynamic distribution of vaccines in an influenza pandemic.
American journal of epidemiology.
169(12):1517-24
[DOI] 10.1093/aje/kwp072.
[PMID] 19395691.
2009
Understanding Australia’s influenza pandemic policy on the strategic use of the antiviral drug stockpile.
The Medical journal of Australia.
191(3):136-7
[PMID] 19645639.
2009
Understanding influenza transmission, immunity and pandemic threats.
Influenza and other respiratory viruses.
3(4):143-9
[DOI] 10.1111/j.1750-2659.2009.00089.x.
[PMID] 19627371.
2008
Impact of emerging antiviral drug resistance on influenza containment and spread: influence of subclinical infection and strategic use of a stockpile containing one or two drugs.
PloS one.
3(6)
[DOI] 10.1371/journal.pone.0002362.
[PMID] 18523549.
2007
A biological model for influenza transmission: pandemic planning implications of asymptomatic infection and immunity.
PloS one.
2(11)
[PMID] 18043733.
2007
Prophylaxis or treatment? Optimal use of an antiviral stockpile during an influenza pandemic.
Mathematical biosciences.
209(2):336-60
[PMID] 17416393.
Contact Details
Phones:
- Business:
- (352) 294-5050
Emails:
- Business:
- jmccaw@ufl.edu
Addresses:
- Business Street:
-
PO Box 103491
GAINESVILLE FL 32610